Redemption Psychiatry is a health care startup founded in 2013, with a mission to provide the highest quality psychiatric care using advanced, evidence-based treatments. The company aims to redeem the practice of Psychiatry for providers and patients, remove the stigma towards mental illness, and stay at the forefront of advancements in psychiatric treatment. Specializing in TRD (Treatment Resistant Depression), the outpatient psychiatric group offers a variety of non-medication treatments, including affordable IV Ketamine Infusion Therapy and TMS (Transcranial Magnetic Stimulation) with innovative laser and image guidance for accurate coil placement. Notably, they also offer additional enhancements to TMS treatment at no cost. While accepting nearly all commercial insurance plans, the company is not a Medicare or AHCCCS provider. As of now, there is no recorded information about their last investment or investors.
There is no investment information
No recent news or press coverage available for Redemption Psychiatry.